Business Wire

The Quad Investors Network Launches with Advisory Board, Expert Groups

20.5.2023 17:43:00 EEST | Business Wire | Press release

Share

The Quad Investors Network formally launched today in parallel with the Quad Leaders meeting in Hiroshima, Japan. The Network is an independent forum of public, private, and philanthropic stakeholders from the four Quad nations, created to foster cooperation, collaboration, and co-investment into critical technologies and supply chain resilience to develop innovative solutions to the greatest economic and security challenges in the Indo-Pacific region. Membership in the network is by invitation only.

Governments participating in the security dialogue, a strategic endeavor between Australia, India, Japan, and the United States, also jointly welcomed the formation of the board and the network’s continued efforts to expand capital and partnership opportunities in critical and emerging technologies across the Quad.

“Critical and emerging technologies will profoundly shape our future. By seeking to accelerate the development and manufacturing of these technologies, from semiconductors to quantum to clean energy, the Quad Investors Network demonstrates the tremendous potential of the Quad nations to mobilize world-class talent and investment to foster a more prosperous, resilient, and innovative Indo-Pacific,” said Jake Sullivan, U.S. National Security Advisor.

As part of the launch, the Quad Investors Network announced the formation of an Advisory Board, composed of world-class business, investment, and thought leaders from the four Quad nations. The Advisory Board includes former Telstra CEO Andy Penn AO; former Australian Ambassador to the United States Arthur Sinodinos AO; Founder and CEO of Breyer Capital Jim Breyer; former Bell Labs President Jeong Kim; Chairman Emeritus of JSR Corporation Koshiba Mitsunobu; and Japan Business Federation Managing Director Hara Ichiro.

“The Quad Investors Network serves as an important, exciting forum for executives, investors, and technologists to collaborate and generate greater co-investment in critical and emerging technologies. These technologies will only grow in importance in the future, and I am honored to be a member of the network’s Advisory Board,” said former Telstra CEO Andy Penn.

The Quad Investors Network also established five expert working groups focused on artificial intelligence, semiconductors, clean energy and critical minerals, mobile networks, and quantum information sciences.

Entrepreneur and investor Karl Mehta will serve as the inaugural Chairman of the Quad Investors Network. Mehta is a serial entrepreneur, author, investor, engineer, and civil servant with more than 30 years of experience in founding, building, and funding technology companies in the U.S. and international markets.

“I am honored to lead, and be a part, of such an august group of individuals and organizations which have come together to work on some of the most pressing critical technology issues facing the Quad,” said Mehta. “I look forward to making further progress and contributing to the economic and national security of the four Quad nations through our efforts.”

Full List of the Quad Investors Network Advisory Board:

  • Thomas Bell, CEO of Leidos
  • Jim Breyer, Founder and CEO of Breyer Capital
  • Kris Gopalakrishnan, Chairman of Axilor Ventures
  • Hara Ichiro, Managing Director of Japan Business Federation
  • Hon. Joe Hockey, Founding Partner and President of Bondi Partners
  • Ashok Jacob, Executive Chairman and Portfolio Manager for Ellerston Capital
  • Lydia Jett, Managing Partner at Softbank Investment Advisers
  • Jeong Kim, Chairman of Kiswe Mobile Inc.
  • Koshiba Mitsunobu, Chairman Emeritus of JSR Corporation
  • Arun Kumar, Managing Partner of Celesta Capital
  • Paul Kwan, General Partner at General Catalyst
  • Nakahama Fumitaka, Managing Corporate Executive and Group Head of Global Corporate and Investment Banking Business at MUFG
  • Jeff Nuechterlein, Managing Partner of Nue Capital LLC
  • Andy Penn AO, Former CEO of Telstra
  • Bec Shrimpton, Defence Strategy and National Security Director at the Australian Strategic Policy Institute
  • Hon. Arthur Sinodinos AO, Former Australian Ambassador to the United States
  • Hon. Sugiyama Shinsuke, Former Japanese Ambassador to the United States
  • Yanase Tadao, Senior Executive Vice President at Nippon Telegraph and Telephone Corporation
  • Ankur Verma, Senior Vice President at Tata Sons

About The Quad Investors Network: The Quad Investors Network (“The Network”) was formed to develop innovative solutions to the greatest economic and security challenges facing the Quad nations in the Indo-Pacific region through joint research, co-investments, and strategic partnerships. The network will be an independent, membership forum composed of leading industry, government, capital market, and academic organizations from the Quad nations.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Alex El-Fakir
201-328-2930
info@quadinvestorsnetwork.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 01:10:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of ORZEYFUL marks a new chapter for the narcolepsy type 1 community, as we introduce an entirely new class of medicine that will potentially redefine how this disease is managed and howpeople feel on treatment,” said Julie Kim, president and chief executive officer of Takeda. “We are proud to have discovered and developed this orexin treatment innovation and will bring it to adults living with NT1 as quickly as possible.” NT1 is a rare, chronic neurological disease d

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 23:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 17:05:00 EEST | Press release

Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership, and operational excellence with a track record of execution from first-in-human studies through regulatory

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 17:00:00 EEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation5.8.2026 16:37:00 EEST | Press release

Speech Processing Solutions, the global leader in AI-assisted professional dictation and documentation solutions sold under the Philips brand, today announced the Philips SpeechLive Legal AI Assistant. The new solution transforms voice recordings, dictation and uploaded sources into structured, ready-to-review legal documents, helping legal professionals work faster while retaining control of the final draft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805997413/en/ The new Philips SpeechLive Legal AI Assistant is designed for turning conversations into ready-to-review legal document drafts. SpeechLive Legal significantly reduces the time needed to transform voice input into structured legal documentation, delivering consistent and high-quality drafts and featuring SpeechLive's built-in integrations with leading case management platforms such as Actionstep, Clio, iManage and NetDocuments, supporting existing billing, e

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye